Global Incidence of Pertussis After the COVID-19 Pandemic
JAMA Network Open · 01.12.2025 · 8 (12) · e2545963
DOI: 10.1001/jamanetworkopen.2025.45963 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 01.12.2025. Verfasst von Andrew Gorringe und 19 weiteren Autor:innen. Beteiligte Einrichtung: UK Health Security Agency, Porton Down, Salisbury, United Kingdom. Hauptthemen laut MEDLINE: Whooping Cough, COVID-19. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Importance Pertussis, or whooping cough, is caused by the Bordetella pertussis bacterium. It induces prolonged cough in all age groups and is a severe, life-threatening disease in young infants. Observations In an online workshop organized by the International Bordetella Society on November 12, 2024, most participating countries reported very low pertussis incidence during and immediately following the COVID-19 pandemic. Since that time, many countries have seen large outbreaks of pertussis, particularly in adolescents. Before the pandemic, several countries, especially those using acellular pertussis vaccine in infants, reported circulating B pertussis isolates that lacked the acellular vaccine antigen pertactin. However, most recent isolates have been found to express this antigen. A rise in macrolide-resistant B pertussis isolates was also reported by several countries. Conclusions and Relevance The potential for large outbreaks of pertussis highlights the importance of maintaining or increasing vaccine coverage in pregnancy and in infants and children. The data presented herein suggest a need for new pertussis vaccines that protect against both disease and infection and that reduce transmission.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- UK Health Security Agency, Porton Down, Salisbury, United Kingdom.
- National Centre for Immunisation Research and Surveillance, the Children's Hospital at Westmead, Sydney, New South Wales, Australia.
- Center for Public Health Action in Applied Epidemiology, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
- Laboratory of Pertussis Control, Department of Bacteriology II, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
- Laboratory of Microbiology, Department of Clinical Laboratory, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China Center, Shanghai, China.
- Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
Zitieren
APA
Gorringe, A., Cavell, B., Beard, F., Tsukada, K., Otsuka, N., Fu, P., Moosa, F., Fabianova, K., Rodrigues, C., Bouchez, V., Toubiana, J., Brisse, S., Dalby, T., He, Q., Campbell, H., Hozbor, D., Hariri, S., Pawloski, L., Scanlon, K., & Edwards, K. (2025). Global Incidence of Pertussis After the COVID-19 Pandemic. JAMA Network Open, 8(12), e2545963. https://doi.org/10.1001/jamanetworkopen.2025.45963
Vancouver
Gorringe A, Cavell B, Beard F, Tsukada K, Otsuka N, Fu P, et al. Global Incidence of Pertussis After the COVID-19 Pandemic. JAMA Network Open. 2025;8(12):e2545963. doi:10.1001/jamanetworkopen.2025.45963
BibTeX
@article{Gorringe2025,
author = {Gorringe, Andrew and Cavell, Breeze and Beard, Frank and Tsukada, Keiko and Otsuka, Nao and Fu, Pan and Moosa, Fahima and Fabianova, Katerina and Rodrigues, Carla and Bouchez, Valerie and Toubiana, Julie and Brisse, Sylvain and Dalby, Tine and He, Qiushui and Campbell, Helen and Hozbor, Daniela and Hariri, Susan and Pawloski, Lucia and Scanlon, Karen and Edwards, Kathryn},
title = {Global Incidence of Pertussis After the COVID-19 Pandemic},
journal = {JAMA Network Open},
year = {2025},
volume = {8},
number = {12},
pages = {e2545963},
doi = {10.1001/jamanetworkopen.2025.45963}
}
EUVIMED